COVID-19 AND PULMONARY THROMBOEMBOLISM: A CASE SERIES

• DOI: 10.22533/at.ed.1593282318048

• Palavras-chave: COVID, Pulmonary thromboembolism, Complications

• Keywords: COVID, Pulmonary thromboembolism, Complications

• Abstract:

  Objective: to perform a review and descriptive analysis of 24 cases of COVID-19 associated with pulmonary thromboembolism seen in the public service in the State of Roraima in 2021. Methods: retrospective review of 24 selected cases of patients who presented with COVID-19 pneumonia and developed pulmonary thromboembolism (PTE) in the year 2021. All patients selected for this study had a confirmed diagnosis of COVID-19 - either by SWAB-RT-PCR or by clinical-epidemiological diagnosis + imaging tests - and a diagnosis of PTE within a period of up to 3 months after the date of hospitalization/diagnosis. Results: the predominant age range among research participants was patients older than 60 years. There was a predominance of obesity (58.3%) and hypertension (50%) as the main comorbidities among patients in the selected group, followed by diabetes mellitus (41.6%). About 75% of the patients required intensive care and of these, 61.1% were admitted to the intensive care unit for a period of more than 10 days. Most study subjects were on prophylaxis with regular use of enoxaparin at a dose appropriate for their weight (79.2% of participants). Conclusion: there is an association between Covid-19 and the presence of coagulopathies, especially in the most critically ill patients.